Insmed | INSM - Umsatzkosten





Umsatzkosten Veränderung Datum
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Cytokinetics USD 160K 104.24M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
Novartis USD 3.54B 7M 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03